EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Silencing Clusterin Could Attenuate the Cell Properties of HCV Core Protein-Expressing HCC Cell Line

Fang Han, Chengjie Cui, Jing Cui, Shuxian Zang, Zhenzhen Zhao, Weiguang Ren, Qingshan Zhang, Lingdi Liu, Shiming Dong, Na Fu, Yuemin Nan

Digestive Diseases and Sciences · 2025

DOI: 10.1007/s10620-025-09560-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2025. Verfasst von Fang Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, No. 139 Ziqiang Road, Shijiazhuang, 050051, Heb…. Hauptthemen laut MEDLINE: Clusterin, Carcinoma, Hepatocellular, Liver Neoplasms, Viral Core Proteins. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Government-funded Project for Outstanding Talents in Clinical Medicine in 2024, Cultivation project of Precision Medicine Joint Fund of Natural Science Foundation of Hebei Province, Funded Project for Introducing Overseas Returnees in Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Global cancer statistics position HCC as the sixth most common malignancy, with mortality rates placing it third. Notably, stress-induced cytoprotective factor CLU is frequently upregulated in HCC, where it has been mechanistically linked to disease progression. Our previous studies demonstrated that CLU is significantly upregulated in the plasma and neoplastic tissues of HCV-induced HCC patients and HCV core protein-expressing HCC cell lines. Our purpose is to elucidate the function and mechanisms of CLU in HCC, particularly in the context of HCV-associated HCC, while also assessing its potential as a drug target. METHODS: The relationship between CLU and genes associated with apoptosis and invasion was analyzed using clinical databases (GEPIA). CLU knockdown-induced alterations in apoptosis and invasion were characterized in HCV core protein-expressing HCC cell lines employing multiple experimental approaches including western blotting, flow cytometry, and transwell assays. RESULTS: CLU expression was positively correlated with anti-apoptotic and pro-invasive genes in HCC. Significant apoptosis induction was achieved through CLU knockdown, mediated by three key molecular changes: pro-apoptotic genes (BAX, PARP, Caspase3, and Caspase9) were upregulated, the anti-apoptotic gene Bcl2 was downregulated, and AKT phosphorylation was inhibited. Additionally, CLU silencing inhibited cellular invasion by diminishing the expression of matrix metalloproteinase 2 (MMP2), N-cadherin and Vimentin. CONCLUSIONS: CLU-mediated regulation of apoptosis and invasion pathways emerges as a critical mechanism in HCC progression according to our data. Our findings demonstrated that CLU is a promising therapeutic target for HCV-associated HCC, providing novel perspectives for developing targeted treatments against this aggressive cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClusterinCarcinoma, HepatocellularLiver NeoplasmsViral Core ProteinsHumansApoptosisCell Line, TumorGene SilencingGene Expression Regulation, NeoplasticNeoplasm InvasivenessHepacivirus

Stichwörter der Autor:innen

ApoptosisClusterinHepatitis C virusHepatocellular carcinomaInvasion

Substanzen

ClusterinCLU protein, humanViral Core Proteinsnucleocapsid protein, Hepatitis C virus

Autor:innen und Institutionen

  • Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, No. 139 Ziqiang Road, Shijiazhuang, 050051, Hebei Province, China.
  • Hebei Provincial Key Laboratory of Liver Fibrosis Mechanism Study in Chronic Liver Diseases, Shijiazhuang, China.
  • Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, No. 139 Ziqiang Road, Shijiazhuang, 050051, Hebei Province, China. 38200273@hebmu.edu.cn.
  • Hebei Provincial Key Laboratory of Liver Fibrosis Mechanism Study in Chronic Liver Diseases, Shijiazhuang, China. 38200273@hebmu.edu.cn.

Förderung

  • Government-funded Project for Outstanding Talents in Clinical Medicine in 2024
  • Cultivation project of Precision Medicine Joint Fund of Natural Science Foundation of Hebei Province
  • Funded Project for Introducing Overseas Returnees in Hebei Province
  • Tracking Project of Applicable Medical Technologies in Hebei Province
  • Funded Project of Three Three Three Talent Project in Hebei Province

Zitieren

APA

Han, F., Cui, C., Cui, J., Zang, S., Zhao, Z., Ren, W., Zhang, Q., Liu, L., Dong, S., Fu, N., & Nan, Y. (2025). Silencing Clusterin Could Attenuate the Cell Properties of HCV Core Protein-Expressing HCC Cell Line. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-025-09560-4

Vancouver

Han F, Cui C, Cui J, Zang S, Zhao Z, Ren W, et al. Silencing Clusterin Could Attenuate the Cell Properties of HCV Core Protein-Expressing HCC Cell Line. Digestive Diseases and Sciences. 2025. doi:10.1007/s10620-025-09560-4

BibTeX
@article{Han2025,
  author = {Han, Fang and Cui, Chengjie and Cui, Jing and Zang, Shuxian and Zhao, Zhenzhen and Ren, Weiguang and Zhang, Qingshan and Liu, Lingdi and Dong, Shiming and Fu, Na and Nan, Yuemin},
  title = {Silencing Clusterin Could Attenuate the Cell Properties of HCV Core Protein-Expressing HCC Cell Line},
  journal = {Digestive Diseases and Sciences},
  year = {2025},
  doi = {10.1007/s10620-025-09560-4}
}
Kostenlos starten →